Live News ›

India Stocks Fall for 6th Week; Pharma Shines Amid Global Fears

RESEARCH-REPORTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
India Stocks Fall for 6th Week; Pharma Shines Amid Global Fears
Overview

Indian stock markets are in their sixth consecutive week of losses, struggling with volatility driven by global geopolitical fears. While a late Thursday rebound offered temporary relief, Nifty Bank pulled down indices, though IT and metal stocks provided some support. Bajaj Finserv AMC's Nimesh Chandan recommends 'staggered purchases' and warns against market timing. Crude oil prices are key for conflict outlook. Market dips are creating value, but investor fear is a barrier. The pharma sector stands out as a favored defensive play due to steady earnings.

Global Fears Deepen Market Slide

Indian stock markets have now lost ground for six straight weeks, with global geopolitical uncertainty weighing heavily on investor sentiment. A late rebound on Thursday provided brief relief, but major indices still ended the day lower. The Nifty Bank index lagged significantly, pulling down the broader market, though IT and metal stocks offered some support. The market is seeing sharp swings driven by news and policy signals, making it a challenging time for traders. The Nifty 50 has a P/E of about 19.62 and a market cap of ₹102.35 lakh crore, while the Nifty Bank index trades at a P/E of 13.7 with a market cap of ₹44.72 lakh crore.

Investor Strategy: Staggered Buys and Oil Watch

Nimesh Chandan, Chief Investment Officer at Bajaj Finserv AMC, advocates for a disciplined approach, recommending 'staggered purchases' to manage risks from market swings and global uncertainty. Investing capital in smaller, consistent tranches is seen as more prudent than lump-sum investments. Commodity markets, especially crude oil, are being closely watched for signs of easing conflict and market expectations. The difference between forward and spot crude oil prices suggests expectations of some easing in current conflicts. Oil prices, while unlikely to drop back to $60–65 a barrel, could stabilize around $85–87, signaling a potential normalization. Current crude oil prices are trading around $108.77 a barrel (as of April 2, 2026). Forecasts suggest stabilization in the mid-to-high $80s or low $90s for the rest of 2026, depending on Middle East conflicts. Goldman Sachs, for example, raised its 2026 Brent forecast to $85 a barrel. This indicates that while immediate price spikes may ease, sustained elevated levels remain a key market factor.

Market Dips Create Value, But Fear Remains

Recent market corrections have revealed attractive valuations beyond large-cap stocks, offering chances to build diversified portfolios. Chandan suggests identifying 50-70 high-quality companies with strong growth and solid finances from the broader market. However, investor sentiment is often held back by behavioral biases, particularly the fear of near-term losses and constant negative news, discouraging investment during downturns. Chandan noted such periods, requiring 'more courage than intellect,' have historically led to long-term wealth creation. The Nifty 50 has shown resilience through past crises like the dot-com bubble (51% drop) and 2008 financial crisis (59% drop), eventually recovering. The benchmark index's current P/E of 19.62 is below its 10-year average of around 22x, indicating valuations may be becoming more reasonable, though potentially still a premium against some emerging market peers.

Pharma Offers Safety; IT Faces AI Disruption

Pharmaceutical stocks are emerging as a relative safe haven amid current uncertainties, thanks to their stable earnings and non-cyclical nature. This defensive trait makes them attractive, especially in a slowing economy, and even valuable if the rupee strengthens due to their strong cash flows. The Indian Pharma Index trades at a P/E of about 33.0, with analysts forecasting 16% annual earnings growth. In contrast, IT stocks, traditionally boosted by currency depreciation, are facing tempered investor interest due to concerns over AI disruption. The Nifty IT index has dropped about 25% year-to-date. Its current P/E ratio is around 20.64, well below its 7-year median of 27.13. Analysts suggest AI could lead to a 2-3% annual reduction in traditional IT services revenue, though it also opens doors for market expansion. Some analysts believe AI disruption fears may be overstated, suggesting a 'reset' rather than an end for the sector. Others highlight risks to application services revenue, a key income source for IT firms. The Nifty Metal index shows a P/E of 19.4.

Bear Case: Global Risks and IT Headwinds

Despite the Nifty 50's resilience in past crises, the current geopolitical climate poses unique challenges. Nomura has downgraded Indian equities to 'Neutral' from 'Overweight,' citing high energy prices from the Iran conflict, AI market challenges, and a potential slowdown in domestic inflows. The brokerage warns that sustained high oil prices and a weaker domestic investment base could pressure valuations, leading it to cut its Nifty target to Rs 24,900. Analysts also point out India's economy is highly vulnerable to rising energy costs due to its heavy reliance on imports. The MSCI India index's forward P/E of 18.9x is a premium compared to Asia ex-Japan valuations. Furthermore, the IT sector faces structural challenges from AI, including potential revenue impacts and job shifts, alongside new opportunities. A prolonged disruption to oil flows via the Strait of Hormuz remains a significant risk. This could keep energy prices higher than expected and hurt corporate earnings, especially for firms with substantial commodity exposure.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.